For Investors
The legal cannabis industry is one of the fastest growing markets in the world with over 30 countries already approving medical cannabis for use in some form. Discover an exciting investment opportunity with Cannhill…
Best Genetics
Through an exclusive partnership with one of Holland’s oldest cannabis seed breeders, Cannhill has access to some of the world’s best quality cannabis genetics. Find out more about the company and our partners….
Export Ready
From seed to end consumer product, Cannhill offers a one stop shop, capable of producing high quality medical cannabis derivatives and products for export around the world. Find out more about our products…
A new direction for health treatment
Medical cannabis products for the health industry
CannHill® is a new phytopharmaceutical licenced company based in Colombia.
The company aims to become a world leading LP (Licensed Producer) of high quality medical cannabis products for domestic and global cannabis markets. In 2018, CannHill® obtained licenses from the Colombian government to cultivate psychoactive and non-psychoactive cannabis.
Production will start at the beginning of 2019 in a purpose built 2.5 hectare facility based near the city of Medellin, a secure and prosperous region of the country. The company is dedicated to producing the cleanest and premium quality cannabis concentrates and extracts.
Using its status as a recognised Colombian cannabis producer and industry knowledge and expertise, CannHill® seeks to build its brand as a global premium provider of medical cannabis products.
